A case of long-term survival with stage IV small cell lung cancer and early-stage central-type squamous cell lung cancer treated by photodynamic therapy

Japanese Journal of Clinical Oncology

Volumn 29, Issue 1, 1999, Pages 45-48

  Kubota, Kaoru ^a,b   Furuse, Kiyoyuki ^a   Kawaguchi, Tomoya ^a   Kawahara, Masaaki ^a   Ogawara, Mitsumasa ^a   Yamamoto, Satoru ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Long term survival; Photodynamic therapy; Small cell lung cancer

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CASE REPORT; HUMAN; LUNG TUMOR; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; PATHOLOGY; PHOTOCHEMOTHERAPY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVOR;

AGED; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SQUAMOUS CELL; PHOTOCHEMOTHERAPY; SURVIVORS;

EID: 0032602185     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.1.45     Document Type: Article

References (18)

1. Cortese DA, Pairolero PC, Bergstraih EJ, Woolner LB, Uhlenhopp MA, Piehler JM, et al. Roentgenographically occult lung cancer. A ten-year experience. J Thorac Cardiovasc Surg 1983;86:373-80.
2. Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol 1992;10:1519-24.
3. Johnson BE, Linnoila RI, Williams JP, Venzon DJ, Okunieff P, Anderson GB, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995;13:101-11.
4. Okunaka T, Kato H, Konaka C, Kawate N, Bonaminio A, Yamamoto H, et al. Photodynamic therapy for multiple primary bronchogenic carcinoma. Cancer 1991;68:253-8.
5. Zelen M. Keynote address on biostatistics and data retrieval, part 3. Cancer Chemother Rep 1973;4:31-42.
6. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
7. DeVore RF, Johnson DH. Chemotherapy of small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, editors, Lung Cancer: Principles and Practice. Philadelphia: Lippincott, 1996;825-35.
8. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med 1992;327:1618-24.
9. Catane R, Lichter A, Lee YJ, Brereton HD, Schwade JG, Glatstein E. Small cell lung cancer: analysis of treatment factors contributing to long-term survival. Cancer 1981;48:1936-43.
10. Turrisi AT, Glover DJ, Mason BA. A. preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 1988;15:183-7.
11. Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF, et al. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin and vincristine. J Clin Oncol 1996;14:806-13.
12. McCracken JD, Janaki LM, Crowley JJ, Taylor SA, Giri PG, Weiss GB. et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J Clin Oncol 1990;8:892-8.
13. Johnson DH, Kim K, Sause R, Komaki R, Wagner H, Aisner S, et al. Cisplatin (P) and etoposide (E) + thoracic radiotherapy (TRT) administered once or twice daily (BID) in limited stage (LS) small cell lung cancer (SCLC): final report of intergroup trial 0096 (abstract). Proc Am Soc Clin Oncol 1996;15:374.
14. Takada M, Fukuoka M, Furuse K, Ariyoshi Y, Ikegami H, Kurita Y, et al. Phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (C) and etoposide (E) for limited-stage (LS) small cell lung cancer (SCLC): preliminary results of the Japan Clinical Oncology Group (JCOG) (abstract). Proc Am Soc Clin Oncol 1996;15:374.
15. Kawai T, Suzuki M, Kono S, Shinomiya N, Rokutanda M, Takagi K, et al. Proliferative cell nuclear antigen and Ki-67 in lung carcinoma. Cancer 1994;74:2468-75.
16. Kato H, Konaka C, Kawate C, Shinohara H, Kinoshita K, Noguchi M, et al. Five-year disease-free survivor of a lung cancer patient treated only by photodynamic therapy. Chest 1986;90:768-70.
17. Hayata Y, Kato H, Konaka C, Amemiya R, Ono J, Ogawa I, et al. Photoradiation therapy with hematoporphyrin derivative in early and stage I lung cancer. Chest 1984;86:169-77.
18. Furuse K, Fukuoka M, Kato H, Horai T, Kubota K, Kodama N, et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. J Clin Oncol 1993;11:1852-7.